Efficacy Comparison of Warfarin Versus Rivaroxaban CVT

• Status: Unknown status
• Trial end date: 2020-05-01
• Target enrollment: 0
• Participant gender: All

Summary

With regard to Cerebral Venous Thrombosis (CVT) importance as a life threatening disease, specific care is necessary, Known anti-coagulants have limitations.Vitamin K antagonists such as Warfarin, require laboratory monitoring and exact administration starting and maintenance dose. although Rivaroxaban(selective and direct Xa factor antagonist ) has no monitoring and no drug interaction. This study aim to focus on efficacy of Warfarin versus Rivaroxaban.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Isfahan University of Medical Sciences
• Treatments: Rivaroxaban; Warfarin

Criteria

IInclusion Criteria:

• Patients of both gender

• Age 18 years and higher

• proven CVT on neuro imaging ( MRI-MRV)

Exclusion Criteria:

• Patients suffering from renal failure(GFR<30) Patients

• Patients with contraindications for oral anticoagulation

• Patient who having pregnancy

• Uncooperative patient for completing the course of treatment